Porras-Garcia Bruno, Ferrer-Garcia Marta, Serrano-Troncoso Eduardo, Carulla-Roig Marta, Soto-Usera Pau, Miquel-Nabau Helena, Olivares Laura Fernández-Del Castillo, Marnet-Fiol Rosa, Santos-Carrasco Isabel de la Montaña, Borszewski Bianca, Díaz-Marsá Marina, Sánchez-Díaz Isabel, Fernández-Aranda Fernando, Gutiérrez-Maldonado José
Department of Clinical Psychology and Psychobiology, University of Barcelona, Passeig de la Vall d'Hebron 171, 08035 Barcelona, Spain.
Department of Child and Adolescent Psychiatry and Psychology, Hospital Sant Joan de Déu of Barcelona, Passeig de Sant Joan de Déu, 2, Esplugues de Llobregat, 08950 Barcelona, Spain.
J Clin Med. 2021 Feb 10;10(4):682. doi: 10.3390/jcm10040682.
In vivo body exposure therapy is considered an effective and suitable intervention to help patients with anorexia nervosa (AN) reduce their body image disturbances (BIDs). However, these interventions have notable limitations and cannot effectively reproduce certain fears usually found in AN, such as the fear of gaining weight (FGW). The latest developments in virtual reality (VR) technology and embodiment-based procedures could overcome these limitations and allow AN patients to confront their FGW and BIDs. This study aimed to provide further evidence of the efficacy of an enhanced (by means of embodiment) VR-based body exposure therapy for the treatment of AN. Thirty-five AN patients (16 in the experimental group, 19 in the control group) participated in the study. FGW, BIDs, and other body-related and ED measures were assessed before and after the intervention and three months later. The experimental group received treatment as usual (TAU) and five additional sessions of VR-based body exposure therapy, while the control group received only TAU. After the intervention, ED symptoms were clearly reduced in both groups, with most of the changes being more noticeable in the experimental group. Specifically, after the intervention and at follow-up, significant group differences were found in the FGW and BIDs, with the experimental group showing significantly lower values than the control group. The current study provides new insights and encouraging findings in the field of exposure-based therapies in AN. VR technology might improve research and clinical practice in AN by providing new tools to help patients confront their core fears (i.e., food- or weight-related cues) and improve their emotional, cognitive, and behavioral responses to their body image.
体内身体暴露疗法被认为是一种有效且合适的干预措施,可帮助神经性厌食症(AN)患者减少其身体意象障碍(BID)。然而,这些干预措施存在显著局限性,无法有效重现通常在AN中发现的某些恐惧,例如对体重增加的恐惧(FGW)。虚拟现实(VR)技术和基于具身化的程序的最新发展可以克服这些局限性,并使AN患者能够直面他们的FGW和BID。本研究旨在为增强型(通过具身化方式)基于VR的身体暴露疗法治疗AN的疗效提供进一步证据。35名AN患者(实验组16名,对照组19名)参与了该研究。在干预前后以及三个月后评估了FGW、BID以及其他与身体相关和进食障碍的指标。实验组接受常规治疗(TAU)以及另外五次基于VR的身体暴露治疗,而对照组仅接受TAU。干预后,两组的进食障碍症状均明显减轻,大多数变化在实验组中更为明显。具体而言,在干预后及随访时,FGW和BID方面发现了显著的组间差异,实验组的值显著低于对照组。本研究为AN领域基于暴露的疗法提供了新的见解和令人鼓舞的发现。VR技术可能会通过提供新工具来帮助患者直面其核心恐惧(即与食物或体重相关的线索),并改善他们对身体意象的情绪、认知和行为反应,从而改善AN的研究和临床实践。